These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 33437202)

  • 21. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Impact of Cell Division Cycle Associated 2 Expression on Pancreatic Ductal Adenocarcinoma.
    Wang MY; Niu ZY; Gao XG; Zhou L; Liao Q; Zhao YP
    Chin Med Sci J; 2016 Sep; 31(3):149-154. PubMed ID: 27733221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma.
    Chen B; Deng T; Deng L; Yu H; He B; Chen K; Zheng C; Wang D; Wang Y; Chen G
    BMC Cancer; 2021 Nov; 21(1):1211. PubMed ID: 34772375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma.
    Li A; Hou S; Chen J; Jiang Y
    Clin Chim Acta; 2021 Jul; 518():156-161. PubMed ID: 33775699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic investigation of the prognostic value of cell division cycle-associated proteins for clear cell renal cell carcinoma patients.
    Meng J; Gao L; Zhang M; Gao S; Fan S; Liang C
    Biomark Med; 2020 Feb; 14(3):223-238. PubMed ID: 31955607
    [No Abstract]   [Full Text] [Related]  

  • 26. Autophagy Regulatory Genes MET and RIPK2 Play a Prognostic Role in Pancreatic Ductal Adenocarcinoma: A Bioinformatic Analysis Based on GEO and TCGA.
    Li X; Li Z; Zhu H; Yu X
    Biomed Res Int; 2020; 2020():8537381. PubMed ID: 33204717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic Analysis of the Clinical Relevance of Cell Division Cycle Associated Family in Endometrial Carcinoma.
    Zhang W; Qiu X; Sun D; Zhang D; Qi Y; Li X; Liu B; Liu J; Lin B
    J Cancer; 2020; 11(19):5588-5600. PubMed ID: 32913454
    [No Abstract]   [Full Text] [Related]  

  • 29. Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients.
    Cui Z; Du L; Wang J; Li Z; Xu J; Ou S; Li D; Li S; Hu H; Chen G; Wu Z
    BMC Cancer; 2022 Dec; 22(1):1354. PubMed ID: 36572856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CDCA1/2/3/5/7/8 as novel prognostic biomarkers and CDCA4/6 as potential targets for gastric cancer.
    Li Z; Liu Z; Li C; Liu Q; Tan B; Liu Y; Zhang Y; Li Y
    Transl Cancer Res; 2021 Jul; 10(7):3404-3417. PubMed ID: 35116645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis.
    Xu D; Wang Y; Zhou K; Wu J; Zhang Z; Zhang J; Yu Z; Liu L; Liu X; Li B; Zheng J
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of leukemia inhibitory factor and its receptor in pancreatic adenocarcinoma.
    Wang D; Liu K; Yang Y; Wang T; Rao Q; Guo W; Zhang Z
    Future Oncol; 2020 Jan; 16(3):4461-4473. PubMed ID: 31854204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LINC01232 Sponges Multiple miRNAs and Its Clinical Significance in Pancreatic Adenocarcinoma Diagnosis and Prognosis.
    Du W; Lei C; Wang Y; Ding Y; Tian P
    Technol Cancer Res Treat; 2021; 20():1533033820988525. PubMed ID: 33506742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma.
    Liang X; Fu Z; Tang L; Zheng M; Chen D; Liu A; Shi L; Yang L; Shao C; Dong X
    BMC Gastroenterol; 2023 Jan; 23(1):2. PubMed ID: 36600208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of cell divisioncycle-associated genes and their prognostic significance in hepatocellular carcinoma.
    Wang Z; Xu J; Zhang S; Chang L
    Int J Clin Exp Pathol; 2021; 14(2):151-169. PubMed ID: 33564348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
    Li Y; Su Z; Wei B; Qin M; Liang Z
    Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune-related genes
    Zhang M; Zeng L; Peng Y; Fan B; Chen P; Liu J
    Future Oncol; 2021 Aug; 17(23):3061-3076. PubMed ID: 34156282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and prognostic impact of FZDs in pancreatic adenocarcinoma.
    Li Y; Liu Z; Zhang Y
    BMC Gastroenterol; 2021 Feb; 21(1):79. PubMed ID: 33618667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
    Shi T; Gao G
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis.
    Tian C; Li X; Ge C
    Mol Med; 2021 Jun; 27(1):62. PubMed ID: 34134622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.